Subscribe to our Newsletters !!


    Here’s what you need to know about Plasma therapy for CORONA virus

    As of late, specialists have discovered that the body can recuperate itself. Platelet-rich plasma treatment is a type of regenerative medication that can bridle those capacities and intensify the regular development factors your body uses to recuperate tissue. What is plasma and what are platelets? Plasma is the fluid part of entire blood. It is

    CDSCO supports foundations to direct clinical preliminaries in COVID-19 Patients

    The Central Drugs Standard Control Organization (CDSCO) has given a green sign to intrigued foundations to direct the clinical preliminary with gaining strength plasma in COVID-19 patients, according to the convention created by Indian Council of Medical Research (ICMR). In a notification in regards to the clinical preliminary of healing plasma in COVID-19 patients, the

    Paper based “Feluda test” to detect COVID19 in minutes

    Feluda, the investigator specialist will presently recognize in minutes on the off chance that you are contaminated with COVID19. In the midst of the developing interest for fast test pack for COVID19, another paper-based test strip has been found by the Institute of Genomics and Integrative Biology (IGIB) in New Delhi. Driven by two Bengali-talking

    Novartis to run COVID-19 preliminary of antimalarial drug

    Novartis has won the thumbs up from the U.S. Nourishment and Drug Administration to direct a randomized preliminary of jungle fever medicate hydroxychloroquine against COVID-19 illness, the Swiss drugmaker said on Monday, to check whether it helps patients. The decades-old nonexclusive medication got FDA crisis use approval this month for its unapproved use for coronavirus

    WHO cautions lifting of coronavirus lockdowns must be steady

    Lockdown measures have demonstrated compelling, and individuals must be prepared for another method for living to permit society to work while the coronavirus is being held under tight restraints, said Takeshi Kasai, WHO Regional Director The World Health Organization cautioned on Tuesday that any lifting of lockdowns to contain the spread of the novel coronavirus

    More than 13 million kids didn’t get any antibodies whatsoever even before COVID-19 disturbed worldwide vaccination-UNICEF

    As the world stands by urgently for an antibody, the COVID-19 pandemic is proceeding to flood over the globe. A large number of youngsters are at risk for missing life-sparing antibodies against measles, diphtheria and polio because of interruptions in vaccination administrations. Last time anyone checked, most nations had suspended mass polio battles and 25

    First new oral polio vaccine in quite a while

    Stage 1 preliminary shows guarantee for fruition of slowed down annihilation exertion; offers exercises for COVID-19 immunization improvement Before being stopped because of the COVID-19 pandemic, a constant immunization crusade had almost prevailing with regards to annihilating polio from the world. Somewhere in the range of 2000 and 2017, the World Health Organization (WHO) assessed

    Sanofi and Regeneron downsize Kevzara’s COVID-19 test

    Accomplices Sanofi (Euronext: SAN) and Regeneron Pharmaceuticals (Nasdaq: REGN) have reported that – following a survey by the Independent Data Monitoring Committee (IDMC) – its examination deal with Kevzara (sarilumab) in COVID-19 will be downsized. The organizations have declared the starter results from the Phase II part of a continuous Phase II/III preliminary assessing the

    China lab rejects COVID-19 frame claims, yet infection roots still a secret

    SHANGHAI Claims that the coronavirus pandemic began in a research facility in the Chinese city of Wuhan have no premise actually, the leader of the lab told Reuters, including that there were still no indisputable answers with regards to where the sickness began. Connivance scholars have guaranteed SARS-CoV-2, presently liable for in excess of 200,000

    Gilead says early aftereffects of coronavirus drug trial show improvement with shorter remdesivir treatment

    Gilead Sciences said Wednesday fundamental aftereffects of a coronavirus medicate preliminary appeared at any rate half of patients treated with a 5-day measurement of antiviral medication remdesivir improved and the greater part were released from the emergency clinic inside about fourteen days. The organization likewise said another preliminary by the National Institute of Allergy and